Researchers have identified an experimental molecule, TOFA, that enables obese subjects to burn fat effectively without the typical side effect of muscle mass loss.
Unlike traditional weight-loss interventions, this drug does not require a reduction in caloric intake, as it directly stimulates the body's metabolic fat-burning processes.
The discovery is being hailed as a potential breakthrough in obesity treatment, offering a new therapeutic pathway that preserves physical strength while promoting significant weight reduction.